National Institute of Mental Health: Notice of Closed Meetings, 49552-49553 [2021-19109]
Download as PDF
<![CDATA[
49552
Federal Register / Vol. 86, No. 169 / Friday, September 3, 2021 / Notices
week prior to each meeting at: https://
www.hhs.gov/paccarb.
Members of the public will have the
opportunity to provide comments live
during the October meeting via
conference line by pre-registering online
at https://www.hhs.gov/paccarb. Preregistration is required for participation
in this session with limited spots
available. Written public comments can
also be emailed to CARB@hhs.gov by
midnight October 1, 2021 and should be
limited to no more than one page. All
public comments received prior to
October 1, 2021, will be provided to
Advisory Council members.
Members of the public will have the
opportunity to provide comments live
during the November 30, 2021 and
December 1, 2021 public meeting via
conference line by pre-registering online
at https://www.hhs.gov/paccarb. There
will be two separate sessions available
for public comment: An Innovation
Spotlight will be held on November 30,
2021 where companies and/or
organizations involved in combating
antibiotic resistance have an
opportunity to present their work to
members of the Advisory Council; and
on December 1, 2021, where all
members of the general public are
welcome to provide oral comment
during this separate session. Preregistration is required for participation
in these sessions with limited spots
available. Further information about
these two sessions can be found online
at https://www.hhs.gov/paccarb. Written
public comments can also be emailed to
CARB@hhs.gov by midnight November
29, 2021 and should be limited to no
more than one page. All public
comments received prior to November
29, 2021, will be provided to Advisory
Council members.
Dated: August 26, 2021.
Jomana F. Musmar,
Designated Federal Officer, Presidential
Advisory Council on Combating AntibioticResistant Bacteria, Office of the Assistant
Secretary for Health.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
lotter on DSK11XQN23PROD with NOTICES1
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
Jkt 253001
Dated: August 31, 2021.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–19110 Filed 9–2–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institute of Mental Health:
Notice of Closed Meetings
BILLING CODE 4150–44–P
16:55 Sep 02, 2021
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Investigator Initiated
Program Project Applications (P01 Clinical
Trial Not Allowed).
Date: September 27–28, 2021.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3E70A,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Soheyla Saadi, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
Fishers Lane, Room 3E70A, Rockville, MD
20852, (240) 669–5178, saadisoh@
niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
National Institutes of Health
[FR Doc. 2021–19027 Filed 9–2–21; 8:45 am]
VerDate Sep<11>2014
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Mental Health Special Emphasis Panel;
Clinical Trials to Test the Effectiveness of
Treatment, Preventive, and Services
Interventions (R01, Collaborative R01, R34).
Date: October 1, 2021.
Time: 9:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Telephone
Conference Call).
Contact Person: Marcy Ellen Burstein,
Ph.D., Scientific Review Officer, Division of
Extramural Activities, National Institute of
Mental Health, NIH, Neuroscience Center,
6001 Executive Blvd., Room 6143, MSC 9606,
Bethesda, MD 20892–9606, 301–443–9699,
bursteinme@mail.nih.gov.
Name of Committee: National Institute of
Mental Health Special Emphasis Panel; Early
Phase Trials of Pharmacological and Device
Based Interventions.
Date: October 5, 2021.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Telephone
Conference Call).
Contact Person: Nicholas Gaiano, Ph.D.,
Review Branch Chief, Division of Extramural
Activities, National Institute of Mental
Health, NIH, Neuroscience Center/Room
6150/MSC 9606, 6001 Executive Boulevard,
Bethesda, MD 20892–9606, 301–443–2742,
nick.gaiano@nih.gov.
Name of Committee: National Institute of
Mental Health Special Emphasis Panel; Pilot
Effectiveness Trials of Interventions for
Preschoolers with ADHD (R34).
Date: October 5, 2021.
Time: 12:00 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Telephone
Conference Call).
Contact Person: Rebecca Steiner Garcia,
Ph.D., Scientific Review Officer, Division of
Extramural Activities, National Institute of
Mental Health, NIH, Neuroscience Center,
6001 Executive Blvd., Room 6149, MSC 9608,
Bethesda, MD 20892–9608, 301–443–4525,
steinerr@mail.nih.gov.
Name of Committee: National Institute of
Mental Health Special Emphasis Panel; NonPharmacological Clinical Trials.
Date: October 8, 2021.
Time: 9:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Telephone
Conference Call).
Contact Person: Nicholas Gaiano, Ph.D.,
Review Branch Chief, Division of Extramural
Activities, National Institute of Mental
Health, NIH, Neuroscience Center/Room
E:\FR\FM\03SEN1.SGM
03SEN1
Federal Register / Vol. 86, No. 169 / Friday, September 3, 2021 / Notices
6150/MSC 9606, 6001 Executive Boulevard,
Bethesda, MD 20892–9606, 301–443–2742,
nick.gaiano@nih.gov.
(Catalogue of Federal Domestic Assistance
Program No. 93.242, Mental Health Research
Grants, National Institutes of Health, HHS)
Dated: August 31, 2021.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–19109 Filed 9–2–21; 8:45 am]
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; National Institute of Allergy
and Infectious Diseases (NIAID) Clinical Site
Monitoring Center (CSMC).
Date: September 9, 2021.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G53,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Konrad Krzewski, Ph.D.,
Scientific Review Officer, Scientific Review
Program, National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G53,
Rockville, MD 20852, 240–747–7526,
konrad.krzewski@nih.gov.
lotter on DSK11XQN23PROD with NOTICES1
DEPARTMENT OF HOMELAND
SECURITY
Office of the Immigration
Detention Ombudsman, U.S.
Department of Homeland Security.
ACTION: Notice of a new system of
records.
AGENCY:
National Institutes of Health
This notice is being published less
than 15 days prior to the meeting due
to the timing limitations imposed by the
review and funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Jkt 253001
BILLING CODE 4140–01–P
Privacy Act of 1974; System of
Records
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
16:55 Sep 02, 2021
[FR Doc. 2021–19105 Filed 9–2–21; 8:45 am]
[Docket No. DHS–2021–0030]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
Dated: August 31, 2021.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
In accordance with the
Privacy Act of 1974, the U.S.
Department of Homeland Security
(DHS) proposes to establish a new DHS
system of records titled, ‘‘DHS/Office of
the Immigration Detention Ombudsman
(OIDO)–001 Office of the Immigration
Detention Ombudsman System of
Records.’’ This system of records allows
DHS/OIDO to collect and maintain
records related to cases brought forth by
individuals or investigations regarding
potential violations of law, individual
rights, standards of professional
conduct, contract terms, or policy
related to immigration detention by any
officer or employee of U.S. Customs and
Border Protection (CBP) or U.S.
Immigration and Customs Enforcement
(ICE), or any contracted, subcontracted,
or cooperating entity personnel.
Additionally, DHS is issuing a Notice of
Proposed Rulemaking to exempt this
system of records from certain
provisions of the Privacy Act, elsewhere
in the Federal Register. This newly
established system will be included in
DHS’s inventory of record systems.
DATES: Submit comments on or before
October 4, 2021. This new system will
be effective upon publication. Routine
uses will be effective October 4, 2021.
ADDRESSES: You may submit comments,
identified by docket number DHS–
2021–0030 by one of the following
methods:
• Federal e-Rulemaking Portal: https://
www.regulations.gov. Follow the
instructions for submitting comments.
• Fax: 202–343–4010.
• Mail: Lynn Parker Dupree, Chief
Privacy Officer, Privacy Office, U.S.
Department of Homeland Security,
Washington, DC 20528–0655.
Instructions: All submissions received
must include the agency name and
docket number DHS–2021–0030. All
SUMMARY:
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
49553
comments received will be posted
without change to https://
www.regulations.gov, including any
personal information provided.
Docket: For access to the docket to
read background documents or
comments received, go to https://
www.regulations.gov.
For
general and privacy questions, please
contact: Lynn Parker Dupree, (202) 343–
1717, Privacy@hq.dhs.gov, Chief Privacy
Officer, Privacy Office, U.S. Department
of Homeland Security, Washington, DC
20528–0655.
SUPPLEMENTARY INFORMATION:
FOR FURTHER INFORMATION CONTACT:
I. Background
The U.S. Department of Homeland
Security (DHS) Office of the
Immigration Detention Ombudsman
(OIDO) is giving notice that it proposes
to establish a new DHS system of
records notice (SORN) titled, ‘‘DHS/
OIDO–001 Office of the Immigration
Detention Ombudsman System of
Records.’’ OIDO is an independent
component within DHS tasked with
reviewing and resolving individual
complaints and providing independent
oversight of immigration detention
facilities, including conducting
announced and unannounced
inspections, reviewing contract terms
for immigration detention facilities and
services, and making recommendations
and reporting to Congress on findings.
OIDO was established by Congress in
Section 106 of the Consolidated
Appropriations Act, 2020 (Pub. L. 116–
93, 133 Stat. 2504 (Dec. 20, 2019), as
codified by 6 U.S.C. 205, which
outlined OIDO’s core responsibilities:
• Establish and administer an
independent, neutral, and confidential
process to receive, investigate, resolve,
and provide redress, including referral
for investigation to the Office of
Inspector General, referral to U.S.
Citizenship and Immigration Services
(USCIS) for immigration relief, or any
other action determined appropriate, for
cases in which Department officers or
other personnel, or contracted,
subcontracted, or cooperating entity
personnel, are found to have engaged in
misconduct or violated the rights of
individuals in immigration detention;
• Establish an accessible and
standardized process regarding
complaints against any officer or
employee of U.S. Customs and Border
Protection (CBP) or U.S. Immigration
and Customs Enforcement (ICE), or any
contracted, subcontracted, or
cooperating entity personnel, for
violations of law, standards of
E:\FR\FM\03SEN1.SGM
03SEN1
]]>Agencies
[Federal Register Volume 86, Number 169 (Friday, September 3, 2021)]
[Notices]
[Pages 49552-49553]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-19109]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Mental Health: Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Mental Health Special
Emphasis Panel; Clinical Trials to Test the Effectiveness of
Treatment, Preventive, and Services Interventions (R01,
Collaborative R01, R34).
Date: October 1, 2021.
Time: 9:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Rockville, MD 20852 (Telephone Conference
Call).
Contact Person: Marcy Ellen Burstein, Ph.D., Scientific Review
Officer, Division of Extramural Activities, National Institute of
Mental Health, NIH, Neuroscience Center, 6001 Executive Blvd., Room
6143, MSC 9606, Bethesda, MD 20892-9606, 301-443-9699,
[email protected].
Name of Committee: National Institute of Mental Health Special
Emphasis Panel; Early Phase Trials of Pharmacological and Device
Based Interventions.
Date: October 5, 2021.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Rockville, MD 20852 (Telephone Conference
Call).
Contact Person: Nicholas Gaiano, Ph.D., Review Branch Chief,
Division of Extramural Activities, National Institute of Mental
Health, NIH, Neuroscience Center/Room 6150/MSC 9606, 6001 Executive
Boulevard, Bethesda, MD 20892-9606, 301-443-2742,
[email protected].
Name of Committee: National Institute of Mental Health Special
Emphasis Panel; Pilot Effectiveness Trials of Interventions for
Preschoolers with ADHD (R34).
Date: October 5, 2021.
Time: 12:00 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Rockville, MD 20852 (Telephone Conference
Call).
Contact Person: Rebecca Steiner Garcia, Ph.D., Scientific Review
Officer, Division of Extramural Activities, National Institute of
Mental Health, NIH, Neuroscience Center, 6001 Executive Blvd., Room
6149, MSC 9608, Bethesda, MD 20892-9608, 301-443-4525,
[email protected].
Name of Committee: National Institute of Mental Health Special
Emphasis Panel; Non-Pharmacological Clinical Trials.
Date: October 8, 2021.
Time: 9:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Rockville, MD 20852 (Telephone Conference
Call).
Contact Person: Nicholas Gaiano, Ph.D., Review Branch Chief,
Division of Extramural Activities, National Institute of Mental
Health, NIH, Neuroscience Center/Room
[[Page 49553]]
6150/MSC 9606, 6001 Executive Boulevard, Bethesda, MD 20892-9606,
301-443-2742, [email protected].
(Catalogue of Federal Domestic Assistance Program No. 93.242, Mental
Health Research Grants, National Institutes of Health, HHS)
Dated: August 31, 2021.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-19109 Filed 9-2-21; 8:45 am]
BILLING CODE 4140-01-P
